Product Information
ERMEZA 150 MCG/5 ML SOLUTION is a brand product labeled by Viatris Specialty LLC, priced at $1.7224 per ML under NDC 49502037875. Its NADAC has been published 40 times since Nov 19, 2025.
FDA first approved this application on Apr 29, 2022.
Strength
30 ug/mL
Manufacturer
Viatris Specialty LLCNDC
49502037875
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA215809FDA Approved
4/29/2022
On Market Since
12/14/2022
Pharmacological Classes
Price Statistics
The NADAC for ERMEZA 150 MCG/5 ML SOLUTION has been published 40 times since Nov 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7224 per ML |
|---|---|
| All-time high | $1.7224 (Aug 19, 2026) |
| All-time low | $1.7224 (Nov 19, 2025) |
| 52-week high | $1.7224 |
| 52-week low | $1.7224 |
| Median price | $1.7224 |
| Average price | $1.7224 |
| Largest weekly change | 0.0% (Nov 26, 2025) |
| Weeks tracked | 40 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levothyroxine sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERMEZA 150 MCG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ERMEZA 150 MCG/5 ML SOLUTION, manufactured by Viatris Specialty LLC, is $1.7224 per ML (NDC 49502037875), effective Aug 19, 2026.
How has the price of ERMEZA 150 MCG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ERMEZA 150 MCG/5 ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 40 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for ERMEZA 150 MCG/5 ML SOLUTION?
Since Nov 19, 2025, the NADAC for ERMEZA 150 MCG/5 ML SOLUTION has ranged from a low of $1.7224 (Nov 19, 2025) to a high of $1.7224 (Aug 19, 2026), with a median of $1.7224 per ML.
Are there cheaper alternatives to ERMEZA 150 MCG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ERMEZA 150 MCG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERMEZA 150 MCG/5 ML SOLUTION?
ERMEZA 150 MCG/5 ML SOLUTION (NDC 49502037875) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.